Wednesday, 16 October 2019

Astellas to accelerate early drug discovery

13 September 2019 | News

Partners with MBC BioLabs

image credit-

image credit-

Astellas Venture Management, LLC, a wholly-owned venture capital subsidiary of Japan based Astellas Pharma Inc., and US based Mission Bay Capital BioLabs, a life-science incubator, have announced their collaboration on the "Golden Ticket Competition".

A Golden Ticket offers entrepreneurial scientists or emerging biotechnology start-ups one-year usage of MBC BioLabs' state-of-the-art lab facility and access to Astellas' research and development (R&D) capabilities and business leaders.

Astellas' sponsorship of the Golden Ticket Competition follows AVM becoming a limited Partner of the venture capital firm Mission Bay Capital in May 2019 and obtaining Gold Sponsorship of MBC BioLabs.

With a shared commitment to discovering and advancing innovative science for the potential future benefit of patients worldwide, AVM and MBC BioLabs are proud to support scientists and early-stage companies to accelerate their novel therapeutic programs, modalities or platforms.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls